Patent · US Active

Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections

US11098051B2 · kind B2 · utility

3Cited by

5References

19Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Rama Jain · Danville, US
Dennis Christofer Koester · Emeryville, US
James R. MANNING · Pleasant Hill, US
Vanessa M. Marx · Pasadena, US
Daniel Poon · Piedmont, US
James Sutton · Princeton Junction, US
Benjamin R. TAFT · Lafayette, US
Lifeng Wan · Richmond, US
Aregahegn Yifru · Benicia, US
Qian Zhao · Louisville, US

Key dates

Filing date	Aug 25, 2017
Grant date	Aug 24, 2021
Priority date	—
Expiry date	Aug 25, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compounds of Formula (I): as further described herein, as well as pharmaceutical compositions comprising such compounds, and methods to use the compounds and pharmaceutical compositions for treatment of certain viral disorders, including influenza.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.